Recent findings have challenged our understanding of depression and dementia. They should also raise questions about our reliance on evidence-based...
Read moreIn healthcare, we have a committee for everything. It is how we meet and how we decide. But it also...
Read moreWhile celebrating the Fourth of July and all that it represents, we pondered whether physicians should do more to protect...
Read moreWe teach medicine through memory. But memorizing facts does little to address the uncertainty that comes out of making decisions...
Read moreA better understanding of the pandemic’s effects on young people is essential to developing policy responses that can address the...
Read moreIn game theory, outcomes depend on the nature of the game and the payoffs. Healthcare is a game of incomplete...
Read moreThe CDC must decide whether to proceed with a new generation of vaccines that promise longer immunity. But many unknowns...
Read moreGlobally, 1.15% of tweets related to COVID-19 vaccines mentioned side effects. Sentiments toward vaccines were on average more negative than...
Read moreDonald Trump is contagious. He infects susceptible patients with a flair for dramatic individualism. And it seems Trumpism will affect...
Read moreOvarian cancer is the most deadly of gynecologic tumors. Fewer than 40% of those diagnosed with ovarian cancer are cured,...
Read moreBefore the COVID-19 pandemic, most people didn’t think through some basic decisions in the same way they might now. In...
Read moreThere have been several cases of doctors expressing skepticism about vaccines in the media.
Read moreClinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy